In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Vbi Vaccines Inc. (NASDAQ:VBIV) reported that Opko Health, Inc. has picked up 6,023,014 of common stock as of 2017-03-31.
The acquisition brings the aggregate amount owned by Opko Health, Inc. to a total of 6,023,014 representing a 15.0% stake in the company.
For those not familiar with the company, VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI’s first marketed product is Sci-B-Vac™, a hepatitis B (“HBV”) vaccine that mimics all three viral surface antigens of the hepatitis B virus; Sci-B-Vacis approved for use in Israel and 14 other countries. VBI’s eVLP Platform technology allows for the development of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic the target virus to elicit a potent immune response. VBI is advancing a pipeline of eVLP vaccines, with lead programs in cytomegalovirus (“CMV”) and glioblastoma multiforme (“GBM”). VBI is also advancing its LPV™ Thermostability Platform, a proprietary formulation and process that allows vaccines and biologics to preserve stability, potency, and safety. VBI is headquartered in Cambridge, MA with research operations in Ottawa, Canada and research and manufacturing facilities in Rehovot, Israel.
A glance at Vbi Vaccines Inc. (NASDAQ:VBIV)’s key stats reveals a current market capitalization of 217.34 Million based on 40.02 Million shares outstanding and a price at last close of $5.49 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-06, Perceptive picked up 3,383,955 at a purchase price of $3.05. This brings their total holding to 6,245,725 as of the date of the filing.
On the sell side, the most recent transaction saw Mcchesney unload 1,500 shares at a sale price of $1.59. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Vbi Vaccines Inc. (NASDAQ:VBIV) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
